M. Shaheen, M. Hassanain, M. Aljiffry, T. Cabrera, P. Chaudhury, È. Simoneau, Nuttawut Kongkaewpaisarn, A. Salman, J. Rivera, M. Jamal, R. Lisbona, A. Khankan, D. Valenti, P. Metrakos (2012)
Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.HPB : the official journal of the International Hepato Pancreato Biliary Association, 14 1
M. Maggard, J. O'connell, C. Ko (2004)
Updated Population-Based Review of Carcinoid TumorsAnnals of Surgery, 240
Shaheen (2012)
Predictors of response to radio-embolization (TheraSphere(R)) treatment of neuroendocrine liver metastasisHPB (Oxford), 14
H. Rajekar, Kashan Bogammana, R. Stubbs (2011)
Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for TreatmentInternational Journal of Hepatology, 2011
Zacharia (2006)
CT of colon cancer metastases to the liver using modified RECIST Criteria: determining the ideal number of target lesions to measureAm J Roentgenol, 186
B. Sangro, Belén Gil-Alzugaray, Javier Rodríguez, I. Sola, A. Martínez-Cuesta, A. Viúdez, A. Chopitea, M. Iñarrairaegui, J. Arbizu, J. Bilbao (2008)
Liver disease induced by radioembolization of liver tumorsCancer, 112
Schell (2002)
Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumorsJ Gastrointest Surg, 6
C. Georgiades, K. Hong, M. D'Angelo, J. Geschwind (2005)
Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.Journal of vascular and interventional radiology : JVIR, 16 12
Khairuddin Memon, R. Lewandowski, M. Mulcahy, A. Riaz, R. Ryu, Kent Sato, Ramona Gupta, P. Nikolaidis, F. Miller, V. Yaghmai, V. Gates, B. Atassi, S. Newman, R. Omary, A. Benson, R. Salem (2012)
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.International journal of radiation oncology, biology, physics, 83 3
A. Saxena, T. Chua, L. Bester, Adel Kokandi, D. Morris (2010)
Factors Predicting Response and Survival After Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases: A Critical Appraisal of 48 CasesAnnals of Surgery, 251
R. Mantravadi, D. Spigos, W. Tan, E. Felix (1982)
Intraarterial yttrium 90 in the treatment of hepatic malignancy.Radiology, 142 3
Bloomston (2007)
Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learnedJ Gastrointest Surg, 11
D. Osborne, E. Zervos, Jonathon Strosberg, Brian Boe, Mokenge Malafa, A. Rosemurgy, T. Yeatman, L. Carey, Lisa Duhaine, L. Kvols (2006)
Improved Outcome With Cytoreduction Versus Embolization for Symptomatic Hepatic Metastases of Carcinoid and Neuroendocrine TumorsAnnals of Surgical Oncology, 13
J. Strosberg, Junsung Choi, A. Cantor, L. Kvols (2006)
Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.Cancer control : journal of the Moffitt Cancer Center, 13 1
Loewe (2003)
Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodolAm J Roentgenol, 180
S. Carter, R. II (2009)
Drug-eluting bead therapy in primary and metastatic disease of the liver.HPB : the official journal of the International Hepato Pancreato Biliary Association, 11 7
R. Chamberlain, D. Canes, K. Brown, L. Saltz, W. Jarnagin, Y. Fong, L. Blumgart (2000)
Hepatic neuroendocrine metastases: does intervention alter outcomes?Journal of the American College of Surgeons, 190 4
Yeul-Hong Kim, J. Ajani, C. Carrasco, P. Dumas, W. Richli, D. Lawrence, V. Chuang, S. Wallace (1999)
Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.Cancer investigation, 17 7
Chamberlain (2000)
Hepatic neuroendocrine metastases: does intervention alter outcomes?J Am Coll Surg, 190
Riaz (2011)
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic?pathologic correlationJ Hepatol, 54
O. Kress, Hans-Joachim Wagner, M. Wied, Klaus Klose, R. Arnold, H. Alfke (2004)
Transarterial Chemoembolization of Advanced Liver Metastases of Neuroendocrine Tumors – A Retrospective Single-Center AnalysisDigestion, 68
K. Brown, B. Koh, L. Brody, G. Getrajdman, J. Susman, Y. Fong, L. Blumgart (1999)
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.Journal of vascular and interventional radiology : JVIR, 10 4
Ho (2007)
Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumorsAm J Roentgenol, 188
Joseph Young, T. Rhee, B. Atassi, V. Gates, L. Kulik, M. Mulcahy, A. Larson, R. Ryu, Kent Sato, R. Lewandowski, R. Omary, R. Salem (2007)
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.Journal of vascular and interventional radiology : JVIR, 18 11
Kent Sato, R. Lewandowski, M. Mulcahy, B. Atassi, R. Ryu, V. Gates, A. Nemcek, O. Barakat, A. Benson, Robert Mandal, M. Talamonti, C. Wong, F. Miller, S. Newman, J. Shaw, Kenneth Thurston, R. Omary, R. Salem (2008)
Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.Radiology, 247 2
S. Schell, E. Camp, J. Caridi, I. Hawkins (2002)
Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumorsJournal of Gastrointestinal Surgery, 6
Yao (2008)
One hundred years after ?carcinoid?: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United StatesJ Clin Oncol, 26
Saxena (2010)
Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastasesAnn Surg, 251
E. Janson, Lars Holmberg, Mats Stridsberg, B. Eriksson, Elvar Theodorsson, Erik Wilander, Kjell Öberg (1997)
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.Annals of oncology : official journal of the European Society for Medical Oncology, 8 7
A. Frilling, J. Li, E. Malamutmann, K. Schmid, A. Bockisch, C. Broelsch (2009)
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic diseaseBritish Journal of Surgery, 96
Therasse (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst, 92
R. Hoffmann, T. Jakobs, C. Kubisch, H. Stemmler, C. Trumm, K. Tatsch, T. Helmberger, M. Reiser (2010)
Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible?European journal of radiology, 74 1
R. Murthy, R. Nunez, J. Szklaruk, W. Erwin, D. Madoff, Sanjay Gupta, K. Ahrar, M. Wallace, Alan Cohen, D. Coldwell, A. Kennedy, M. Hicks (2005)
Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.Radiographics : a review publication of the Radiological Society of North America, Inc, 25 Suppl 1
Kwang-hun Lee, K. Sung, Do-yun Lee, Sang Park, Ki Kim, Jeong-Sik Yu (2002)
Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein.Radiographics : a review publication of the Radiological Society of North America, Inc, 22 5
R. Murthy, P. Kamat, R. Nunez, D. Madoff, Sanjay Gupta, R. Salem, James Yao (2008)
Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.Journal of vascular and interventional radiology : JVIR, 19 1
Javier Nazario, Sanjay Gupta (2010)
Transarterial liver-directed therapies of neuroendocrine hepatic metastases.Seminars in oncology, 37 2
K. Buchanan, C. Johnston, M. O'Hare, J. Ardill, C. Shaw, J. Collins, R. Watson, A. Atkinson, D. Hadden, T. Kennedy, J. Sloan (1986)
Neuroendocrine tumors. A European view.The American journal of medicine, 81 6B
R. Salem, R. Lewandowski, Carol Roberts, J. Goin, Kenneth Thurston, M. Abouljoud, A. Courtney (2004)
Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.Journal of vascular and interventional radiology : JVIR, 15 4
R. Salem, Kenneth Thurston (2006)
Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.Journal of vascular and interventional radiology : JVIR, 17 8
Touzios (2005)
Neuroendocrine hepatic metastasesAnn Surg, 241
Hyo‐suk Lee, Joo-Sung Kim, I. Choi, J. Chung, Jae Park, C. Kim (1997)
The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstructionCancer, 79
M. Bloomston, O. Alsaif, D. Klemanski, Joseph Pinzone, Edward Martin, Bryan Palmer, G. Guy, H. Khabiri, E. Ellison, Manisha Shah (2007)
Hepatic Artery Chemoembolization in 122 Patients with Metastatic Carcinoid Tumor: Lessons LearnedJournal of Gastrointestinal Surgery, 11
A. Ruutiainen, M. Soulen, C. Tuite, T. Clark, J. Mondschein, S. Stavropoulos, S. Trerotola (2007)
Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.Journal of vascular and interventional radiology : JVIR, 18 7
D. Madoff, Sanjay Gupta, K. Ahrar, R. Murthy, James Yao (2006)
Update on the management of neuroendocrine hepatic metastases.Journal of vascular and interventional radiology : JVIR, 17 8
Salem (2006)
Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerationsJ Vasc Interv Radiol, 17
Murthy (2008)
Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolizationJ Vasc Interven Radiol, 19
I. Modlin, K. Lye, M. Kidd (2003)
A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 97
S. Gaur, J. Friese, C. Sadow, R. Ayyagari, C. Binkert, M. Schenker, M. Kulke, R. Baum (2011)
Hepatic Arterial Chemoembolization Using Drug-Eluting Beads in Gastrointestinal Neuroendocrine Tumor Metastatic to the LiverCardioVascular and Interventional Radiology, 34
T. Baère, F. Deschamps, Christophe Teriitheau, P. Rao, Kenneth Conengrapht, M. Schlumberger, S. Leboulleux, E. Baudin, Lukas Hechellhammer (2008)
Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.Journal of vascular and interventional radiology : JVIR, 19 6
P. Paprottka, R. Hoffmann, A. Haug, W. Sommer, F. Raessler, C. Trumm, G. Schmidt, N. Ashoori, M. Reiser, T. Jakobs (2012)
Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 MicrospheresCardioVascular and Interventional Radiology, 35
R. Lewandowski, L. Kulik, A. Riaz, S. Senthilnathan, M. Mulcahy, R. Ryu, S. Ibrahim, Kent Sato, Talia Baker, F. Miller, R. Omary, M. Abecassis, R. Salem (2009)
A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus RadioembolizationAmerican Journal of Transplantation, 9
Fynn Rw (1959)
One hundred years after.The Central African journal of medicine, 5
K. Hong, J. McBride, C. Georgiades, D. Reyes, J. Herman, I. Kamel, J. Geschwind (2009)
Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.Journal of vascular and interventional radiology : JVIR, 20 3
D. Granberg, L. Eriksson, S. Welin, H. Kindmark, E. Janson, B. Skogseid, K. Öberg, B. Eriksson, R. Nyman (2007)
Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumorsActa Radiologica, 48
R. Lencioni, J. Llovet (2010)
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.Seminars in liver disease, 30 1
T. Vogl, T. Gruber, N. Naguib, R. Hammerstingl, N. Nour-Eldin (2009)
Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.AJR. American journal of roentgenology, 193 4
S. Dominguez, A. Denys, Idalina Madeira, P. Hammel, V. Vilgrain, Y. Menu, P. Bernades, P. Ruszniewski (2000)
Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumoursEuropean Journal of Gastroenterology & Hepatology, 12
Mph MD, M. Jong, M. Bloomston, C. Pulitano, B. Clary, S. Reddy, MS MD, Scott Celinski, D. Kooby, C. Staley, J. Stokes, Carrie Chu, D. Arrese, A. Ferrero, R. Schulick, M. Choti, J. Geschwind, Jennifer Strub, T. Bauer, R. Adams, L. Aldrighetti, G. Mentha, L. Capussotti, M. MD (2011)
Surgery Versus Intra-arterial Therapy for Neuroendocrine Liver Metastasis: A Multicenter International AnalysisAnnals of Surgical Oncology, 18
Brown (1999)
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptomsJ Vasc Interv Radiol, 10
Vogl (2009)
Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocolsAm J Roentgenol, 193
A. Ho, J. Picus, M. Darcy, B. Tan, J. Gould, T. Pilgram, Daniel Brown (2007)
Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.AJR. American journal of roentgenology, 188 5
S. Musunuru, Herb Chen, S. Rajpal, Nicholas Stephani, J. McDermott, K. Holen, L. Rikkers, S. Weber (2006)
Metastatic neuroendocrine hepatic tumors: resection improves survival.Archives of surgery, 141 10
C. Loewe, M. Schindl, M. Cejna, B. Niederle, J. Lammer, S. Thurnher (2003)
Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results.AJR. American journal of roentgenology, 180 5
T. Zacharia, S. Saini, E. Halpern, James Sumner (2006)
CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure.AJR. American journal of roentgenology, 186 4
A. Roche, B. Girish, T. Debaere, M. Ducreux, D. Elias, A. Laplanche, Boige, M. Schlumberger, P. Ruffle, E. Baudin (2004)
Prognostic factors for chemoembolization in liver metastasis from endocrine tumors.Hepato-gastroenterology, 51 60
G. Limouris, A. Chatziioannou, D. Kontogeorgakos, D. Mourikis, M. Lyra, P. Dimitriou, A. Stavraka, A. Gouliamos, L. Vlahos (2008)
Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastasesEuropean Journal of Nuclear Medicine and Molecular Imaging, 35
D. Desai, T. O'dorisio, W. Schirmer, Stephen Jung, H. Khabiri, Violet Villanueva, E. Martin (2001)
Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumorsRegulatory Peptides, 96
Y. Sato, H. Watanabe, M. Sone, H. Onaya, N. Sakamoto, K. Osuga, M. Takahashi, S. Yamamoto, Y. Arai (2009)
Inter- and intra-criteria reproducibility of RECIST ver 1.1 and modified EASL (European Association for the Study of the Liver) tumor response criteria to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): From the dataset of JIVROSG (Japan Interventional Radiology in OncologJournal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15_suppl
J. Drougas, L. Anthony, T. Blair, R. Lopez, J. Wright, W. Chapman, Laura Webb, M. Mazer, S. Meranze, C. Pinson (1998)
Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors.American journal of surgery, 175 5
M. Kalinowski, M. Dressler, A. König, M. El-Sheik, A. Rinke, H. Höffken, T. Gress, R. Arnold, K. Klose, H. Wagner (2009)
Selective Internal Radiotherapy with Yttrium-90 Microspheres for Hepatic Metastatic Neuroendocrine Tumors: A Prospective Single Center StudyDigestion, 79
A. Kennedy, W. Dezarn, Patrick McNeillie, D. Coldwell, C. Nutting, D. Carter, R. Murthy, S. Rose, R. Warner, David Liu, H. Palmedo, C. Overton, Bonita Jones, R. Salem (2008)
Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 PatientsAmerican Journal of Clinical Oncology, 31
J. Touzios, J. Kiely, Susan Pitt, W. Rilling, E. Quebbeman, Stuart Wilson, H. Pitt (2005)
Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival?Annals of Surgery, 241
E. Diamandidou, J. Ajani, David Yang, Vincent Chuang, Cynthia Brown, Humberto Carrasco, David Lawrence, Sidney Wallace (1998)
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.AJR. American journal of roentgenology, 170 2
J. Gates, George Hartnell, Keith Stuart, Melvin Clouse (1999)
Chemoembolization of hepatic neoplasms: safety, complications, and when to worry.Radiographics : a review publication of the Radiological Society of North America, Inc, 19 2
I. Modlin, A. Sándor (2000)
An analysis of 8305 cases of carcinoid tumorsCancer, 79
J. Strosberg, A. Cheema, L. Kvols (2011)
A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.Cancer control : journal of the Moffitt Cancer Center, 18 2
L. Kulik, B. Atassi, Lodewijk Holsbeeck, T. Souman, R. Lewandowski, M. Mulcahy, R. Hunter, A. Nemcek, M. Abecassis, Kenneth Haines, R. Salem (2006)
Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantationJournal of Surgical Oncology, 94
C. Ray, C. Battaglia, A. Libby, A. Prochazka, Stanley Xu, B. Funaki (2012)
Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective.Journal of vascular and interventional radiology : JVIR, 23 3
A. Frilling, G. Sotiropoulos, Jun Li, O. Kornasiewicz, U. Plöckinger (2010)
Multimodal management of neuroendocrine liver metastases.HPB : the official journal of the International Hepato Pancreato Biliary Association, 12 6
L. Kulik, B. Carr, M. Mulcahy, R. Lewandowski, B. Atassi, R. Ryu, Kent Sato, A. Benson, A. Nemcek, V. Gates, M. Abecassis, R. Omary, R. Salem (2007)
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosisHepatology, 47
Pitt (2008)
Hepatic neuroendocrine metastases: chemo- or bland embolization?J Gastrointest Surg, 12
Theresa Harring, N. Nguyen, J. Goss, C. O’mahony (2011)
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors: A Comprehensive ReviewInternational Journal of Hepatology, 2011
A. Riaz, Khairuddin Memon, F. Miller, P. Nikolaidis, L. Kulik, R. Lewandowski, R. Ryu, Kent Sato, V. Gates, M. Mulcahy, Talia Baker, E. Wang, Ramona Gupta, R. Nayar, A. Benson, M. Abecassis, R. Omary, R. Salem (2011)
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation.Journal of hepatology, 54 4
J. Shim, H. Lee, Seon-Ok Kim, Y. Shin, K. Kim, Y. Lim, D. Suh (2012)
Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models.Radiology, 262 2
A. Riaz, R. Lewandowski, L. Kulik, M. Mulcahy, Kent Sato, R. Ryu, R. Omary, R. Salem (2009)
Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.Journal of vascular and interventional radiology : JVIR, 20 9
B. Eriksson, E. Larsson, B. Skogseid, A. Löfberg, L. Lörelius, K. Öberg (1998)
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumorsCancer, 83
T. Rhee, R. Lewandowski, David Liu, M. Mulcahy, Gary Takahashi, P. Hansen, A. Benson, A. Kennedy, R. Omary, R. Salem (2008)
90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors: Preliminary Results From a Multi-institutional ExperienceAnnals of Surgery, 247
Daniel Brown, J. Gould, D. Gervais, S. Goldberg, R. Murthy, S. Millward, W. Rilling, J. Geschwind, R. Salem, S. Vedantham, J. Cardella, M. Soulen (2007)
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria.Journal of vascular and interventional radiology : JVIR, 20 7 Suppl
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New Guidelines to Evaluate the Response to Treatment in Solid Tumors.Journal of the National Cancer Institute, 92 3
Diamandidou (1998)
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumorsAm J Roentgenol, 170
Ryan Whitney, V. Válek, J. Fagés, Agustin Garcia, G. Narayanan, C. Tatum, Michael Hahl, R. Martin (2011)
Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost.The oncologist, 16 5
M. Iñarrairaegui, Kenneth Thurston, J. Bilbao, D. D’Avola, Macarena Rodríguez, J. Arbizu, A. Martínez-Cuesta, B. Sangro (2010)
Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.Journal of vascular and interventional radiology : JVIR, 21 8
S. Laçin, Ilker Oz, E. Ozkan, O. Kucuk, S. Bilgiç (2011)
Intra-arterial treatment with 90yttrium microspheres in treatment-refractory and unresectable liver metastases of neuroendocrine tumors and the use of 111in-octreotide scintigraphy in the evaluation of treatment response.Cancer biotherapy & radiopharmaceuticals, 26 5
R. Salem, R. Lewandowski, L. Kulik, E. Wang, A. Riaz, R. Ryu, Kent Sato, Ramona Gupta, P. Nikolaidis, F. Miller, V. Yaghmai, S. Ibrahim, S. Senthilnathan, Talia Baker, V. Gates, B. Atassi, S. Newman, Khairuddin Memon, Richard Chen, R. Vogelzang, A. Nemcek, S. Resnick, H. Chrisman, J. Carr, R. Omary, M. Abecassis, A. Benson, M. Mulcahy (2011)
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.Gastroenterology, 140 2
Susan Pitt, Jaime Knuth, James Keily, J. McDermott, S. Weber, He-zhong Chen, W. Rilling, E. Quebbeman, D. Agarwal, H. Pitt (2008)
Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?Journal of Gastrointestinal Surgery, 12
M. Mcstay, D. Maudgil, M. Williams, J. Tibballs, A. Watkinson, M. Caplin, J. Buscombe (2005)
Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.Radiology, 237 2
de Baere (2008)
Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary resultsJ Vasc Interv Radiol, 19
Dara Christante, Suellen Pommier, B. Givi, R. Pommier (2008)
Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.Surgery, 144 6
D. Kooby, Vasili Egnatashvili, S. Srinivasan, A. Chamsuddin, K. Delman, J. Kauh, C. Staley, Hyun Kim (2010)
Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.Journal of vascular and interventional radiology : JVIR, 21 2
James Yao, Manal Hassan, A. Phan, Cecile Dagohoy, C. Leary, J. Mares, E. Abdalla, J. Fleming, J. Vauthey, A. Rashid, Douglas Evans (2008)
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 18
Ruutiainen (2007)
Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liverJ Vasc Interv Radiol, 18
R. Dhanasekaran, D. Kooby, C. Staley, J. Kauh, B. Barron, J. Montilla-Soler, Hyun Kim (2009)
Radioembolization vs. chemoembolization for unresectable neuroendocrine tumor hepatic metastasesThe Journal of Nuclear Medicine, 50
M. Pentecost, J. Daniels, G. Teitelbaum, P. Stanley (1993)
Hepatic chemoembolization: safety with portal vein thrombosis.Journal of vascular and interventional radiology : JVIR, 4 3
Rhee (2008)
90Y radioembolization for metastatic neuroendocrine liver tumorsAnn Surg, 247
Sanjay Gupta, Marcella Johnson, R. Murthy, K. Ahrar, M. Wallace, D. Madoff, S. McRae, M. Hicks, S. Rao, J. Vauthey, J. Ajani, James Yao (2005)
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumorsCancer, 104
Madoff (2006)
Update on the management of neuroendocrine hepatic metastasesJ Vasc Interv Radiol, 17
Surgical Oncology – Pubmed
Published: Apr 16, 2013
Access the full text.
Sign up today, get DeepDyve free for 14 days.